Cutaneous melanoma
Eggermont, Alexander MM, Prof, Spatz, Alan, MD, Robert, Caroline, MD
Published in The Lancet (British edition) (01.03.2014)
Published in The Lancet (British edition) (01.03.2014)
Get full text
Journal Article
Safety profiles of anti-CTLA-4 and anti-PD-1 antibodies alone and in combination
Boutros, Celine, Tarhini, Ahmad, Routier, Emilie, Lambotte, Olivier, Ladurie, Francois Leroy, Carbonnel, Franck, Izzeddine, Hassane, Marabelle, Aurelien, Champiat, Stephane, Berdelou, Armandine, Lanoy, Emilie, Texier, Matthieu, Libenciuc, Cristina, Eggermont, Alexander M. M., Soria, Jean-Charles, Mateus, Christine, Robert, Caroline
Published in Nature reviews. Clinical oncology (01.08.2016)
Published in Nature reviews. Clinical oncology (01.08.2016)
Get full text
Journal Article
The new era of adjuvant therapies for melanoma
Eggermont, Alexander M. M., Robert, Caroline, Ribas, Antoni
Published in Nature reviews. Clinical oncology (01.09.2018)
Published in Nature reviews. Clinical oncology (01.09.2018)
Get full text
Journal Article
Diagnosis and treatment of melanoma. European consensus-based interdisciplinary guideline – Update 2016
Garbe, Claus, Peris, Ketty, Hauschild, Axel, Saiag, Philippe, Middleton, Mark, Bastholt, Lars, Grob, Jean-Jacques, Malvehy, Josep, Newton-Bishop, Julia, Stratigos, Alexander J, Pehamberger, Hubert, Eggermont, Alexander M
Published in European journal of cancer (1990) (01.08.2016)
Published in European journal of cancer (1990) (01.08.2016)
Get full text
Journal Article
Impact of Precision Medicine in Diverse Cancers: A Meta-Analysis of Phase II Clinical Trials
Schwaederle, Maria, Zhao, Melissa, Lee, J Jack, Eggermont, Alexander M, Schilsky, Richard L, Mendelsohn, John, Lazar, Vladimir, Kurzrock, Razelle
Published in Journal of clinical oncology (10.11.2015)
Published in Journal of clinical oncology (10.11.2015)
Get full text
Journal Article
Improved Survival with Vemurafenib in Melanoma with BRAF V600E Mutation
Chapman, Paul B, Hauschild, Axel, Robert, Caroline, Haanen, John B, Ascierto, Paolo, Larkin, James, Dummer, Reinhard, Garbe, Claus, Testori, Alessandro, Maio, Michele, Hogg, David, Lorigan, Paul, Lebbe, Celeste, Jouary, Thomas, Schadendorf, Dirk, Ribas, Antoni, O'Day, Steven J, Sosman, Jeffrey A, Kirkwood, John M, Eggermont, Alexander M.M, Dreno, Brigitte, Nolop, Keith, Li, Jiang, Nelson, Betty, Hou, Jeannie, Lee, Richard J, Flaherty, Keith T, McArthur, and Grant A
Published in The New England journal of medicine (30.06.2011)
Published in The New England journal of medicine (30.06.2011)
Get full text
Journal Article
New drugs in melanoma: It’s a whole new world
Eggermont, Alexander M.M, Robert, Caroline
Published in European journal of cancer (1990) (01.09.2011)
Published in European journal of cancer (1990) (01.09.2011)
Get full text
Journal Article
Translational control of tumor immune escape via the eIF4F–STAT1–PD-L1 axis in melanoma
Cerezo, Michaël, Guemiri, Ramdane, Druillennec, Sabine, Girault, Isabelle, Malka-Mahieu, Hélène, Shen, Shensi, Allard, Delphine, Martineau, Sylvain, Welsch, Caroline, Agoussi, Sandrine, Estrada, Charlène, Adam, Julien, Libenciuc, Cristina, Routier, Emilie, Roy, Séverine, Désaubry, Laurent, Eggermont, Alexander M., Sonenberg, Nahum, Scoazec, Jean Yves, Eychène, Alain, Vagner, Stéphan, Robert, Caroline
Published in Nature Medicine (01.12.2018)
Published in Nature Medicine (01.12.2018)
Get full text
Journal Article
Magazine Article
Predictive Gene Signature in MAGE-A3 Antigen-Specific Cancer Immunotherapy
ULLOA-MONTOYA, Fernando, LOUAHED, Jamila, BRICHARD, Vincent G, DIZIER, Benjamin, GRUSELLE, Olivier, SPIESSENS, Bart, LEHMANN, Frédéric F, SUCIU, Stefan, KRUIT, Wim H. J, EGGERMONT, Alexander M. M, VANSTEENKISTE, Johan
Published in Journal of clinical oncology (01.07.2013)
Published in Journal of clinical oncology (01.07.2013)
Get full text
Journal Article
KEYNOTE-716: Phase III study of adjuvant pembrolizumab versus placebo in resected high-risk stage II melanoma
Luke, Jason J, Ascierto, Paolo A, Carlino, Matteo S, Gershenwald, Jeffrey E, Grob, Jean-Jacques, Hauschild, Axel, Kirkwood, John M, Long, Georgina V, Mohr, Peter, Robert, Caroline, Ross, Merrick, Scolyer, Richard A, Yoon, Charles H, Poklepovic, Andrew, Rutkowski, Piotr, Anderson, James R, Ahsan, Sama, Ibrahim, Nageatte, M Eggermont, Alexander M
Published in Future oncology (London, England) (01.01.2020)
Published in Future oncology (London, England) (01.01.2020)
Get full text
Journal Article
Adjuvant ipilimumab versus placebo after complete resection of high-risk stage III melanoma (EORTC 18071): a randomised, double-blind, phase 3 trial
Eggermont, Alexander M M, Prof, Chiarion-Sileni, Vanna, MD, Grob, Jean-Jacques, Prof, Dummer, Reinhard, Prof, Wolchok, Jedd D, MD, Schmidt, Henrik, MD, Hamid, Omid, MD, Robert, Caroline, Prof, Ascierto, Paolo A, Prof, Richards, Jon M, MD, Lebbé, Céleste, Prof, Ferraresi, Virginia, MD, Smylie, Michael, MD, Weber, Jeffrey S, MD, Maio, Michele, MD, Konto, Cyril, MD, Hoos, Axel, MD, de Pril, Veerle, MSc, Gurunath, Ravichandra Karra, MD, de Schaetzen, Gaetan, PhD, Suciu, Stefan, PhD, Testori, Alessandro, MD
Published in The lancet oncology (01.05.2015)
Published in The lancet oncology (01.05.2015)
Get full text
Journal Article
Improved Endpoints for Cancer Immunotherapy Trials
Hoos, Axel, Eggermont, Alexander M. M., Janetzki, Sylvia, Hodi, F. Stephen, Ibrahim, Ramy, Anderson, Aparna, Humphrey, Rachel, Blumenstein, Brent, Old, Lloyd, Wolchok, Jedd
Published in JNCI : Journal of the National Cancer Institute (22.09.2010)
Published in JNCI : Journal of the National Cancer Institute (22.09.2010)
Get full text
Journal Article
Impact of a Biomarker-Based Strategy on Oncology Drug Development: A Meta-analysis of Clinical Trials Leading to FDA Approval
Jardim, Denis L, Fontes Jardim, Denis L, Schwaederle, Maria, Wei, Caimiao, Lee, J Jack, Hong, David S, Eggermont, Alexander M, Schilsky, Richard L, Mendelsohn, John, Lazar, Vladimir, Kurzrock, Razelle
Published in JNCI : Journal of the National Cancer Institute (01.11.2015)
Published in JNCI : Journal of the National Cancer Institute (01.11.2015)
Get full text
Journal Article
Association Between Immune-Related Adverse Events and Recurrence-Free Survival Among Patients With Stage III Melanoma Randomized to Receive Pembrolizumab or Placebo: A Secondary Analysis of a Randomized Clinical Trial
Eggermont, Alexander M M, Kicinski, Michal, Blank, Christian U, Mandala, Mario, Long, Georgina V, Atkinson, Victoria, Dalle, Stéphane, Haydon, Andrew, Khattak, Adnan, Carlino, Matteo S, Sandhu, Shahneen, Larkin, James, Puig, Susana, Ascierto, Paolo A, Rutkowski, Piotr, Schadendorf, Dirk, Koornstra, Rutger, Hernandez-Aya, Leonel, Di Giacomo, Anna Maria, van den Eertwegh, Alfonsus J M, Grob, Jean-Jacques, Gutzmer, Ralf, Jamal, Rahima, Lorigan, Paul C, Krepler, Clemens, Ibrahim, Nageatte, Marreaud, Sandrine, van Akkooi, Alexander, Robert, Caroline, Suciu, Stefan
Published in JAMA oncology (01.04.2020)
Published in JAMA oncology (01.04.2020)
Get more information
Journal Article
eIF4F is a nexus of resistance to anti-BRAF and anti-MEK cancer therapies
Boussemart, Lise, Malka-Mahieu, Hélène, Girault, Isabelle, Allard, Delphine, Hemmingsson, Oskar, Tomasic, Gorana, Thomas, Marina, Basmadjian, Christine, Ribeiro, Nigel, Thuaud, Frédéric, Mateus, Christina, Routier, Emilie, Kamsu-Kom, Nyam, Agoussi, Sandrine, Eggermont, Alexander M., Désaubry, Laurent, Robert, Caroline, Vagner, Stéphan
Published in Nature (London) (04.09.2014)
Published in Nature (London) (04.09.2014)
Get full text
Journal Article
Cancer immunotherapy: Opportunities and challenges in the rapidly evolving clinical landscape
Emens, Leisha A, Ascierto, Paolo A, Darcy, Phillip K, Demaria, Sandra, Eggermont, Alexander M.M, Redmond, William L, Seliger, Barbara, Marincola, Francesco M
Published in European journal of cancer (1990) (01.08.2017)
Published in European journal of cancer (1990) (01.08.2017)
Get full text
Journal Article